Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data

Interpretation of clinical trials to alter the decline in β-cell function after diagnosis of type 1 diabetes depends on a robust understanding of the natural history of disease. Combining data from the Type 1 Diabetes TrialNet studies, we describe the natural history of β-cell function from shortly...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenbaum, Carla J., Beam, Craig A., Boulware, David, Gitelman, Stephen E., Gottlieb, Peter A., Herold, Kevan C., Lachin, John M., McGee, Paula, Palmer, Jerry P., Pescovitz, Mark D., Krause-Steinrauf, Heidi, Skyler, Jay S., Sosenko, Jay M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402330/
https://www.ncbi.nlm.nih.gov/pubmed/22688329
http://dx.doi.org/10.2337/db11-1538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402330/
https://www.ncbi.nlm.nih.gov/pubmed/22688329
http://dx.doi.org/10.2337/db11-1538

Ejemplares similares